Journavx, a new non-opioid pain medication, offers a safer alternative for managing acute pain while reducing the risk of ...

Dr. Sanjay Gupta said Tuesday that the approval of a new non-opioid pain medication is “a pretty big deal.” “This is a pretty ...

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

New research from McGill University reveals that listening to music at your own rhythm can significantly reduce pain.

12 Simple Decor Choices That Instantly Make Your Home Look More Expensive Near-Earth asteroid Bennu could hit Earth in 157 ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

The new FDA-approved pain drug is suzetrigine, with the brand name Journavx. Suzetrigine is designed to alleviate moderate to ...

The opioid epidemic continues to affect hundreds of thousands of people, but there may be hope for the future with a new, non ...

While New Orleans prepares for the excitement of the big game, it’s important to remember that sports injuries aren’t limited to the professionals. High school athletes, weekend warriors, and generall ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

Librela (bedinvetmab injection) is a monthly injectable monoclonal antibody, for which real-world drug experience data has ...